238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Analyze DCF forecasts for the company and compare them with competitors.
813.39B
Revenue has increased from the previous period.
18.37%
Revenue growth rate has increased from the previous period.
284.30B
EBITDA has increased from the previous period.
34.95%
EBITDA margin has increased from the previous period.
243.05B
EBIT has increased from the previous period.
29.88%
EBIT margin has increased from the previous period.
41.25B
Depreciation has increased from the previous period.
378.60B
Total cash has decreased from the previous period.
46.55%
Cash percentage has decreased from the previous period.
125.65B
Receivables have increased from the previous period.
15.45%
Receivables percentage has decreased from the previous period.
2.92B
Inventories have decreased from the previous period.
0.36%
Inventory percentage has decreased from the previous period.
19.42B
Accounts payable has increased from the previous period.
2.39%
Payables percentage has decreased from the previous period.
-95.01B
Capital expenditure has increased from the previous period.
-11.68%
CapEx percentage has increased from the previous period.
8.76%
WACC has decreased from the previous period.
8.83%
Cost of equity has decreased from the previous period.
4.06%
Cost of debt has decreased from the previous period.
1.01
Beta has decreased from the previous period.
12.45B
Diluted shares outstanding has decreased from the previous period.
25.46B
Total debt has decreased from the previous period.
2.07T
Total equity has decreased from the previous period.
2.09T
Total capital has decreased from the previous period.
1.22%
Debt weighting has increased from the previous period.
98.78%
Equity weighting has decreased from the previous period.
204.78B
EBIAT has increased from the previous period.
134.09B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
2.93T
Terminal value has increased from the previous period.
2.30T
Enterprise value has increased from the previous period.
2.00B
Net debt has decreased from the previous period.
2.29T
Equity value has increased from the previous period.
184.35
Equity value per share has increased from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
162.72B
The estimated revenue has increased from the previous period.
47.73B
The estimated EBITDA has increased from the previous period.
2.32
The estimated EPS has increased from the previous period.
31.39B
The estimated net income has increased from the previous period.
32.17B
The estimated EBIT has increased from the previous period.
26.44B
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$187.00
Analysts expect the stock price to decrease by 22.34%.
Buy
Positive consensus among analysts.
